Protective effects of E-CG-01 (3,4-lacto cycloastragenol) against bleomycin-induced lung fibrosis in C57BL/6 mice
Open Access
- 29 June 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 177, 117016
Abstract
No abstract availableKeywords
Funding Information
- Ege Üniversitesi (TOA-2019-20914)
This publication has 52 references indexed in Scilit:
- Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in miceBiomedicine & Pharmacotherapy, 2019
- Cycloastragenol ameliorates experimental heart damage in rats by promoting myocardial autophagy via inhibition of AKT1-RPS6KB1 signalingBiomedicine & Pharmacotherapy, 2018
- Nuclear Factor–Erythroid-2–Related Factor 2 in Aging and Lung FibrosisThe American Journal of Pathology, 2016
- Elastase modifies bleomycin-induced pulmonary fibrosis in miceActa Histochemica, 2016
- Mice with Pulmonary Fibrosis Driven by Telomere DysfunctionCell Reports, 2015
- Preventive Effect of Chrysin on Bleomycin-Induced Lung Fibrosis in RatsInflammation, 2014
- Oxidative stress and pulmonary fibrosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Idiopathic Pulmonary Fibrosis: Pathobiology of Novel Approaches to TreatmentClinics in Chest Medicine, 2012
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000
- Determination of malonaldehyde precursor in tissues by thiobarbituric acid testAnalytical Biochemistry, 1978